Your browser doesn't support javascript.
loading
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab.
Giraldo, Nicolas A; Nguyen, Peter; Engle, Elizabeth L; Kaunitz, Genevieve J; Cottrell, Tricia R; Berry, Sneha; Green, Benjamin; Soni, Abha; Cuda, Jonathan D; Stein, Julie E; Sunshine, Joel C; Succaria, Farah; Xu, Haiying; Ogurtsova, Aleksandra; Danilova, Ludmila; Church, Candice D; Miller, Natalie J; Fling, Steve; Lundgren, Lisa; Ramchurren, Nirasha; Yearley, Jennifer H; Lipson, Evan J; Cheever, Mac; Anders, Robert A; Nghiem, Paul T; Topalian, Suzanne L; Taube, Janis M.
Afiliação
  • Giraldo NA; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Nguyen P; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Engle EL; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Kaunitz GJ; The Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA.
  • Cottrell TR; Department of Oncology, Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Berry S; The Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA.
  • Green B; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Soni A; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Cuda JD; Department of Oncology, Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Stein JE; The Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA.
  • Sunshine JC; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Succaria F; The Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA.
  • Xu H; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Ogurtsova A; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Danilova L; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Church CD; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Miller NJ; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Fling S; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lundgren L; The Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA.
  • Ramchurren N; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Yearley JH; Department of Biostatistics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lipson EJ; The Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA.
  • Cheever M; Division of Dermatology, Department of Medicine, University of Washington Medical Center, Seattle, WA, USA.
  • Anders RA; Division of Dermatology, Department of Medicine, University of Washington Medical Center, Seattle, WA, USA.
  • Nghiem PT; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Topalian SL; Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Taube JM; Division of Dermatology, Department of Medicine, University of Washington Medical Center, Seattle, WA, USA.
J Immunother Cancer ; 6(1): 99, 2018 10 01.
Article em En | MEDLINE | ID: mdl-30285852
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Célula de Merkel / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Célula de Merkel / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido